I think a standardized title when I comment on my current column is a good idea.
Today, the topic is biotech. The most interesting observation is that a bunch of them gapped up nicely in July, including HGSI, CELG, AMGN, PDLI (sort of) and AFFX. I’ll let someone else figure out why CRA gapped down.
Anyway, the point was that there was a lot of oomph in July yet biotechs as a group 1) lagged the market and 2) started to retreat rather than hitting new highs with the Spoos.
Obamacare? Not my area.
